According to a recent meta-analysis, severe hypertension was reported in 7.4%, coronary ischemia in 1.7%, arterial thromboembolism in 1.8% and cardiac dysfunction in 2.3% of patients receiving VEGF inhibitors [14]. The gene discussed is VEGFA; the disease is hypertensive disorder.